Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2
作者:Matias Casás-Selves、Andrew X. Zhang、James E. Dowling、Stefan Hallén、Aarti Kawatkar、Nicholas J. Pace、Christopher R. Denz、Timothy Pontz、Farzin Garahdaghi、Qing Cao、Alan Sabirsh、Kumar Thakur、Nichole O'Connell、Jun Hu、Iván Cornella-Taracido、Eranthie Weerapana、Michael Zinda、Robert A. Goodnow、M. Paola Castaldi
DOI:10.1002/cmdc.201700028
日期:2017.6.21
confirmatory cellular and biochemical assays, we found that this chemicalseriesinhibits ATP synthesis by uncoupling the mitochondrial potential. Affinity chemoproteomics experiments identified sarco(endo)plasmic reticulum Ca2+ -dependent ATPase (SERCA2) as a binding partner of the TDZ series, and subsequent validation studies suggest that the TDZ series can act as ionophores through SERCA2 toward Wnt pathway
PIDA-mediated oxidative aromatic C N bond cleavage: Efficient methodology for the synthesis of 1,2-diaza-1,3-dienes under ambient conditions
作者:Abhishek Kumar、Sarita Katiyar、Arvind Kumar Jaiswal、Ruchir Kant、Koneni V. Sashidhara
DOI:10.1016/j.tetlet.2021.153252
日期:2021.8
Antibacterial compounds
申请人:Genzyme Corporation
公开号:US06410533B1
公开(公告)日:2002-06-25
The present invention provides compounds having useful antibacterial activity and pharmaceutical compositions comprising one or more of these compounds. The invention further relates to a method of treating a bacterial infection in a patient, comprising administering to the patient an effective mount of one or more of the antibacterial compounds of the invention.